$5.25
0.00 (0%)
Caraco Pharmaceutical Laboratories Ltd. (AMEX:CPD.DL)
CAPS Rating:
The Company is engaged in the business of developing, manufacturing, marketing and distributing generic and private-label pharmaceuticals to the wholesalers, distributors, warehousing and non-warehousing chain drugstores and managed care providers.
RSS Headlines
Fool UK
Recs
The FDA's shutdown of CPD's manufacturing operations has scared investors away, but lots of recent capital spending and last week's press release imply that the FDA will allow CPD to resume production sometime soon. Even without manufacturing, CPD has continued to generate a positive operating cash flow as Sun Pharmaceutical's US distributor, and its current cash on hand is about 3.5x debt. So we're pretty safe on the downside, and we can expect a big PPS bump with the resumption of Manufacturing operations.